Digestives & Intestinal Remedies - BRICS

  • BRICS
  • In 2024, the revenue in the Digestives & Intestinal Remedies market market in BRICS amounts to US$6.38bn.
  • This market is projected to experience an annual growth rate of 2.10% from 2024 to 2029 (CAGR 2024-2029).
  • Among the BRICS countries, in China generates the highest revenue in this market, amounting to US$4,408.00m in 2024.
  • When considering the total population figures, per person revenues of US$1.94 are generated in 2024.
  • In Brazil, the Digestives & Intestinal Remedies market is booming due to the growing interest in natural and herbal remedies.

Key regions: Canada, United States, Australia, Brazil, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in BRICS is experiencing significant growth due to changing customer preferences and local special circumstances.

Customer preferences:
Customers in the Digestives & Intestinal Remedies market in BRICS are increasingly seeking natural and herbal remedies for digestive issues. This shift in preference is driven by a growing awareness of the potential side effects of traditional pharmaceutical products. Consumers are also becoming more health-conscious and are looking for products that offer long-term benefits rather than just temporary relief. Additionally, there is a rising demand for products that are easy to consume and have a pleasant taste, as consumers seek convenience and a positive experience when addressing their digestive health.

Trends in the market:
In Brazil, there is a growing trend towards probiotic supplements and fermented foods, as consumers recognize the importance of maintaining a healthy gut microbiome. This trend is also observed in Russia, where consumers are increasingly turning to natural remedies such as kefir and kombucha. In China, there is a rising demand for traditional Chinese medicine (TCM) remedies for digestive issues, as consumers have a long-standing belief in the efficacy of TCM in treating various ailments. India, on the other hand, is witnessing a surge in the consumption of Ayurvedic remedies for digestive health, as consumers embrace their traditional healing practices. South Africa is experiencing a similar trend, with consumers showing a preference for herbal remedies that align with their cultural beliefs.

Local special circumstances:
In Brazil, the high prevalence of gastrointestinal disorders, such as irritable bowel syndrome (IBS), is driving the demand for Digestives & Intestinal Remedies. This is also the case in Russia, where the consumption of processed and unhealthy foods has led to an increase in digestive issues. In China, the aging population and changing dietary habits have contributed to a higher incidence of digestive problems, creating a need for effective remedies. In India, the widespread use of spices and heavy meals has led to a higher prevalence of digestive disorders, leading consumers to seek appropriate remedies. South Africa, with its diverse population and cultural practices, has a unique demand for Digestives & Intestinal Remedies that cater to different ethnic groups and their specific dietary habits.

Underlying macroeconomic factors:
The growing middle class in BRICS countries is a key driver of the Digestives & Intestinal Remedies market. As disposable incomes rise, consumers are willing to spend more on healthcare products, including those for digestive health. Additionally, urbanization and changing lifestyles have resulted in an increase in sedentary jobs and unhealthy eating habits, leading to a higher demand for remedies to address digestive issues. Furthermore, the increasing prevalence of chronic diseases, such as obesity and diabetes, has created a need for Digestives & Intestinal Remedies that can help manage these conditions. Overall, the Digestives & Intestinal Remedies market in BRICS is expected to continue growing as consumers prioritize their digestive health and seek effective and natural solutions for their ailments.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)